These changes include a reduction in tumor vasculature, a decrease in myeloid-derived suppressor cells (MDSCs), an increase in M1-like tumor-associated macrophages (TAMs) and infiltrating CD8+ cells, and a decrease in M2-like TAM levels. Here, CD8A is linked to neoplasm.